Natural born killers: How the body's frontline immune cells decide which cells to destroy
Natural Killer (NK) cells - a type of white blood cell - are a major component of the human body's innate immune system. Over 1,000 NK cells are found in every drop of blood. They provide a fast frontline defence against tumours, viruses and bacterial infections, by latching onto and killing cells in the human body that are cancerous or are infected with a virus or a bacterial pathogen. On their journey round the human body NK cells regularly latch onto normal non-diseased cells too, before moving off, leaving them unharmed. Previously, the process by which NK cells made the right decision to kill or not kill another cell was unclear.
Now, a team of researchers from Imperial College London have used high speed microscopy imaging techniques to observe the NK cell decision making process in action. This has revealed striking differences in the behaviour of NK cells when interacting with healthy or diseased cells. The outcome of the decision making process is determined by how receptors on the surface of the NK cell interact with proteins on the surface of the captured cell. Every NK cell has two types of surface receptors - activators, which turn the killing mechanism 'on' and inhibitors which turn the killing mechanism 'off'.
Professor Davis and his colleagues discovered that if a captured cell is diseased or cancerous, it interacts with a large number of the NK cell's activating receptors, which makes the NK cell stop dead in its tracks and spread out over the captured cell. During this spreading process the NK cell continuously reads the 'on' and 'off' signals from its surface contact with the captured cell. If the 'on' signals dominate, the NK cell prolongs contact with the captured cell and eventually kills it.
Conversely if the captured cell is healthy, it interacts with more of the NK cell's inhibiting receptors - and fewer of its activating receptors - meaning that the 'off' signals dominate and the 'stopping and spreading' process does not occur, allowing the NK cell to quickly move off in search of a new target.
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.